Repository logo
 

Electrophoretic drug delivery for seizure control.

Published version
Peer-reviewed

Type

Article

Change log

Authors

Proctor, Christopher M  ORCID logo  https://orcid.org/0000-0002-2066-1354
Slézia, Andrea 

Abstract

The persistence of intractable neurological disorders necessitates novel therapeutic solutions. We demonstrate the utility of direct in situ electrophoretic drug delivery to treat neurological disorders. We present a neural probe incorporating a microfluidic ion pump (μFIP) for on-demand drug delivery and electrodes for recording local neural activity. The μFIP works by electrophoretically pumping ions across an ion exchange membrane and thereby delivers only the drug of interest and not the solvent. This "dry" delivery enables precise drug release into the brain region with negligible local pressure increase. The therapeutic potential of the μFIP probe is tested in a rodent model of epilepsy. The μFIP probe can detect pathological activity and then intervene to stop seizures by delivering inhibitory neurotransmitters directly to the seizure source. We anticipate that further tailored engineering of the μFIP platform will enable additional applications in neural interfacing and the treatment of neurological disorders.

Description

Keywords

Animals, Drug Delivery Systems, GABA Agents, Mice, Microfluidics, Seizures, gamma-Aminobutyric Acid

Journal Title

Sci Adv

Conference Name

Journal ISSN

2375-2548
2375-2548

Volume Title

4

Publisher

American Association for the Advancement of Science (AAAS)